+47.6%
GSK vs TRU
-2.1%
+49.8%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | TRU | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.2% | -0.8% | +1.0% | +0.2% |
| 7D | -3.6% | -6.5% | +2.9% | -3.1% |
| 30D | -5.9% | -2.5% | -3.4% | -5.8% |
| 3M | -4.3% | +10.4% | -14.6% | -4.8% |
| 6M | -10.8% | +1.6% | -12.4% | -11.0% |
| YTD | +1.8% | -9.7% | +11.5% | +2.1% |
| 1Y | +23.5% | -17.3% | +40.7% | +24.4% |
| All | +47.6% | -2.1% | +49.8% | +52.1% |
Cumulative growth
Daily Returns
Daily percentage return beside TRU.
Daily Out/Under-Performance
Portfolio return minus TRU return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × TRU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded TRU wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling